Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

CIK: 0001844645 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 12, 2022

Total Value ($000): $198,504 (100.0% shares, 0.0% debt)

Holdings (11)

— KARUNA THERAPEUTICS INC 56.2%

Value ($000) $111,513 Shares 881,458 Est. Cost $102.40 Unrealized —

PCVX VAXCYTE INC 9.1%

Value ($000) $18,108 Shares 832,166 Est. Cost $37.18 Unrealized -37.8%

— RALLYBIO CORP 8.6%

Value ($000) $17,148 Shares 2,271,311 Est. Cost $17.58 Unrealized —

— INOZYME PHARMA INC 6.4%

Value ($000) $12,694 Shares 2,661,154 Est. Cost $14.26 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 6.1%

Value ($000) $12,126 Shares 569,041 Est. Cost $24.49 Unrealized -16.3%

— AKOUOS INC 4.2%

Value ($000) $8,414 Shares 1,794,088 Est. Cost $19.83 Unrealized —

— EXSCIENTIA PLC 4.2%

Value ($000) $8,410 Shares 772,285 Est. Cost $19.76 Unrealized —

— FUSION PHARMACEUTICALS INC 2.0%

Value ($000) $3,887 Shares 1,560,982 Est. Cost $11.75 Unrealized —

— BOLT BIOTHERAPEUTICS INC 1.9%

Value ($000) $3,859 Shares 1,891,467 Est. Cost $32.91 Unrealized —

— VIGIL NEUROSCIENCE INC 0.7%

Value ($000) $1,446 Shares 560,595 Est. Cost $7.03 Unrealized —

— ALIGOS THERAPEUTICS INC 0.5%

Value ($000) $899 Shares 743,215 Est. Cost $27.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	KARUNA THERAPEUTICS INC	881,458	$111,513	56.2%	$102.40	—	COM	48576A100
PCVX	VAXCYTE INC	832,166	$18,108	9.1%	$37.18	-37.8%	COM	92243G108
—	RALLYBIO CORP	2,271,311	$17,148	8.6%	$17.58	—	COM	75120L100
—	INOZYME PHARMA INC	2,661,154	$12,694	6.4%	$14.26	—	COM	45790W108
ARQT	ARCUTIS BIOTHERAPEUTICS INC	569,041	$12,126	6.1%	$24.49	-16.3%	COM	03969K108
—	AKOUOS INC	1,794,088	$8,414	4.2%	$19.83	—	COM	00973J101
—	EXSCIENTIA PLC	772,285	$8,410	4.2%	$19.76	—	ADS	30223G102
—	FUSION PHARMACEUTICALS INC	1,560,982	$3,887	2.0%	$11.75	—	COM	36118A100
—	BOLT BIOTHERAPEUTICS INC	1,891,467	$3,859	1.9%	$32.91	—	COM	097702104
—	VIGIL NEUROSCIENCE INC	560,595	$1,446	0.7%	$7.03	—	COM	92673K108
—	ALIGOS THERAPEUTICS INC	743,215	$899	0.5%	$27.65	—	COM	01626L105